Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Retrospective Analysis of Imaging and Clinical Features From Patients Treated With Brolucizumab in Post-marketing Setting With Reports of Intraocular Inflammation and/or Retinal Vascular Occlusion
Authors not listed
Novartis Pharmaceuticals · 2021
Abstract
This non-interventional descriptive study was undertaken to better understand the most common imaging features associated with inflammation arising in the post-marketing setting when brolucizumab was prescribed in routine clinical practice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2021). Retrospective Analysis of Imaging and Clinical Features From Patients Treated With Brolucizumab in Post-marketing Setting With Reports of Intraocular Inflammation and/or Retinal Vascular Occlusion. <em>Novartis Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT05657158
Vancouver
Anonymous. Retrospective Analysis of Imaging and Clinical Features From Patients Treated With Brolucizumab in Post-marketing Setting With Reports of Intraocular Inflammation and/or Retinal Vascular Occlusion. Novartis Pharmaceuticals. 2021.
BibTeX
@misc{anon2021Retros,
title = {Retrospective Analysis of Imaging and Clinical Features From Patients Treated With Brolucizumab in Post-marketing Setting With Reports of Intraocular Inflammation and/or Retinal Vascular Occlusion},
author = {Anonymous},
journal = {Novartis Pharmaceuticals},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Institut National de la Santé Et de la Recherche Médicale, France 2010
Open access · US-GOV
Observational, Follow-up Study of Adaptive Optics Retinal Imaging in Controls and During Retinal or General Diseases
University Hospital, Grenoble 2014
Open access · US-GOV
Cognitive Mechanisms and Cerebral Substrate of Naming Impairment During Aging. Behavior and Neuroimaging Approaches.
International Journal of Molecular Sciences 2022
Open access · CC-BY
Biological Age Predictors: The Status Quo and Future Trends
Bayer 2016
Open access · US-GOV
A retrospecTive and Prospective Non-Interventional Study to Assess the Clinical pracTice in Real Life for Patients With Wet AMD Refractory to raNibizumab and Switching to Aflibercept
Celgene 2016
Open access · US-GOV
Retrospective Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Clinica Universidad de Navarra, Universidad de Navarra 2021
Open access · US-GOV